Drug information: agents for the treatment of arrhythmias. Therapeutic main group: anti-arrhythmia agents. 16. (3) . Anti-arrhythmia agents with action on ventricular arrhythmias
Lumholtz, I.B.
Sygeplejersken 81(2): 15
1981
ISSN/ISBN: 0106-8350 PMID: 6908256 Document Number: 177621
Document emailed within 1 workday
Related Documents
Lumholtz, I.B. 1980: Drug information: agents for the treatment of arrhythmias. Therapeutic main group: anti-arrhythmia agents. 14. Digitalis glycosides Sygeplejersken 80(50): 13Di Blase, G.; Tabarroni, F.; Bonavita, E.; Marzara, G.; Di Taranto, A.; Spagna, I. 1971: Electrophysiological mechanism of arrhythmias and of the most common anti-arrhythmia agents Bollettino Della Societa Italiana di Cardiologia 16(9): 579-582
Kurbanov, R.D.; Azimova, N.A.; Kiakbaev, G.K.; Abdullaev, T.A.; Asriiants, L.S.; Zakirov, N.U.; Avezov, D.K.; Faĭzullaev, B.P. 1993: Thrombocyte aggregation in patients with cardiac arrhythmias and effect of anti-arrhythmia agents Kardiologiia 33(5): 27-29
Tuna, J.L. 1992: Classification of anti-arrhythmia drugs and their mechanism of action. Iatrogeny of anti-arrhythmia agents Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 11(4): 385-386
Lumholtz, I.B. 1977: Drug information: agents in the treatment of neoplastic diseases. Therapeutic main group: cytostatic agents. 1 Sygeplejersken 77(16): 13
Leclercq, J.F.; Attuel, P.; Milosevic, D.; Coumel, P. 1979: Quantitative evaluation of the efficacy of anti-arrhythmia agents in chronic ventricular arrhythmia Acta Cardiologica 34(1): 35-50
Bracchetti, D.; Mantovani, B.; Naccarella, F.; Lombardi, G.; Palmieri, M. 1980: Evaluation of the efficacy of anti-arrhythmia agents in hyperkinetic ventricular arrhythmia Bollettino Della Societa Italiana di Cardiologia Suppl: 117-123
Lumholtz, I.B. 1978: Drug information. Therapeutic main group: current anti-inflammatory agents and milder-acting analgesics. Diclophenac (Voltaren) Sygeplejersken 78(28): 20
Storozhuk, B.G. 1985: Anti-arrhythmia activity and side effects of various anti-arrhythmia agents Vrachebnoe Delo 3: 41-44
Lumholtz, I.B. 1980: Drug information. Therapeutic main group: agents for the treatment of angina pectoris. 10th and last part. 4. other angina pectoris agents Sygeplejersken 80(20): 23
Bonhorst, D. 1992: Choice of anti-arrhythmia agents: the arrhythmia-patient binomial Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 11(4): 387-389
Hohnloser, S.H.; Meinertz, T.; Mehender, M.; Geibel, A.; Just, H. 1988: Induction and increase of cardiac arrhythmia by anti-arrhythmia agents Der Internist 29(5): 338-344
Lumholtz, I.B. 1978: Drug information: current anti-inflammatory agents and weaker-acting analgesics. Therapeutic main group: sulindac (Clinoril), fenoprofen (Fenoprofen), tolmetin (Tolectin), diclofenamid (Voltaren) Sygeplejersken 78(22): 11
Aupetit, J.F.; Timour, Q.; Chevrel, G.; Omar, S.; Loufoua-Moundanga, J.; Faucon, G. 1993: Comparative study of different classes of anti-arrhythmia agents on the vulnerability of ischemic ventricular fibrillation Therapie 48(4): 403-407
Mazurowa, A.; Szadowska, A.; Szmigielski, A. 1972: Combined action on the heart of beta adrenergic blocking agents and anti-arrhythmia drugs Kardiologia Polska 15(2): 167-175
Du, Z.H.; Liu, H.G.; Zeng, F.D.; Hu, C.J. 1988: Effects of dauricine combined with other anti-arrhythmia agents on electrically induced ventricular fibrillation in rabbits Zhongguo Yao Li Xue Bao 9(1): 33-36
Lumholtz, I.B. 1980: Drug information: agents for the treatment of cardiac arrhythmias. 1 Sygeplejersken 80(22): 26
Burkhardt, D.; Steinbrunn, W.; Kaufmann, G. 1973: Modification by lidocain and other anti-arrhythmia agents on the combination of fixed and variably coupled ectopic ventricular beats Schweizerische Medizinische Wochenschrift 103(50): 1787-1789
Knipping, W. 1980: Problems of evaluating rare adverse drug reactions using as an example agranulocytosis induced by anti-arrhythmia agents Medizinische Klinik 75(3): 108-115
Lumholtz, I.B. 1979: Drug information: agents for the treatment of gynecologic diseases. Therapeutic main group: gonadotropins, human chorionic gonadotropin (HCG) Sygeplejersken 79(30): 25